Skip to content

A Comparative Study on the Effects of Super Minimally Invasive Surgery and Organ-Resection Surgery for Gastric Tumors on Brain Function

A Comparative Study on the Effects of Super Minimally Invasive Surgery and Organ-Resection Surgery for Gastric Tumors on Brain Function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121338
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach tumor

Interventions

Super minimally invasive surgery group, organ excision surgery group:None
Organ resection surgery group:None

Sponsors

General Hospital of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 70 years, right-handed. 2.Diagnosed with a digestive tract tumor (including gastric intraepithelial neoplasia, gastric cancer, subepithelial gastric tumors, etc.), and undergoing digestive tract surgery for the first time; 3.No history of neurological or psychiatric diseases; 4.Cranial CT or MRI shows no abnormalities in the brain.

Exclusion criteria

Exclusion criteria: 1.Patients who are contraindicated for general anesthesia. 2.Patients who have previously received radiotherapy or chemotherapy. 3.Patients with a history of cranial disease or related surgery. 4.Patients with a history of alcohol abuse, abuse of central nervous system stimulants or depressants, and those who have had severe postoperative complications. 5.Presence of implanted metallic electronic devices in the body.

Design outcomes

Primary

MeasureTime frame
Whole-brain functional connectivity strength;Blood oxygen level dependent signal activation intensity;Clinical and Behavioral Questionnaire Indicators;

Secondary

MeasureTime frame
Gastrin;Growth Hormone-Releasing Peptide;Glucagon-Like Peptide-1;Ghrelin; Leptin; Cholecystokinin;

Countries

China

Contacts

Public ContactEnQiang LingHu

General Hospital of the Chinese People's Liberation Army

linghuenqiang@vip.sina.com+86 135 0123 3558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026